These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37715438)

  • 21. Pro-Inflammatory of PRDM1/SIRT2/NLRP3 Axis in Monosodium Urate-Induced Acute Gouty Arthritis.
    Zhao Q; Xia N; Xu J; Wang Y; Feng L; Su D; Cheng Z
    J Innate Immun; 2023; 15(1):614-628. PubMed ID: 37385228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators.
    Dhanasekar C; Rasool M
    Eur J Pharmacol; 2016 Sep; 786():116-127. PubMed ID: 27268719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation.
    Wang Y; Zhu W; Lu D; Zhang C; Wang Y
    Int Immunopharmacol; 2021 Nov; 100():108107. PubMed ID: 34482265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin analogue AI-44 alleviates MSU-induced gouty arthritis in mice via inhibiting cathepsin B-mediated NLRP3 inflammasome activation.
    Gu Y; Zhu Y; Deng G; Liu S; Sun Y; Lv W
    Int Immunopharmacol; 2021 Apr; 93():107375. PubMed ID: 33517224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P2X7R Mediates the Synergistic Effect of ATP and MSU Crystals to Induce Acute Gouty Arthritis.
    Li X; Wan A; Liu Y; Li M; Zhu Z; Luo C; Tao J
    Oxid Med Cell Longev; 2023; 2023():3317307. PubMed ID: 36686377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis.
    Hao K; Jiang W; Zhou M; Li H; Chen Y; Jiang F; Hu Q
    Int J Biol Sci; 2020; 16(16):3163-3173. PubMed ID: 33162822
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological basis for use of madecassoside in gouty arthritis: anti-inflammatory, anti-hyperuricemic, and NLRP3 inhibition.
    Lu X; Zeng R; Lin J; Hu J; Rong Z; Xu W; Liu Z; Zeng W
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):277-284. PubMed ID: 31084401
    [No Abstract]   [Full Text] [Related]  

  • 28. Mastoparan M Suppressed NLRP3 Inflammasome Activation by Inhibiting MAPK/NF-κB and Oxidative Stress in Gouty Arthritis.
    Yan Y; Yu L; Chen B; Cao C; Zhao H; Wang Q; Xie D; Xi Y; Zhang C; Cheng J
    J Inflamm Res; 2023; 16():6179-6193. PubMed ID: 38116368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A wild rice-derived peptide R14 ameliorates monosodium urate crystals-induced IL-1β secretion through inhibition of NF-κB signaling and NLRP3 inflammasome activation.
    Charoenwutthikun S; Chanjitwiriya K; Roytrakul S; Kunthalert D
    PeerJ; 2023; 11():e15295. PubMed ID: 37197585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanosensitive TRPV4 is required for crystal-induced inflammation.
    Lan Z; Chen L; Feng J; Xie Z; Liu Z; Wang F; Liu P; Yue X; Du L; Zhao Y; Yang P; Luo J; Zhu Z; Hu X; Cao L; Lu P; Sah R; Lavine K; Kim B; Hu H
    Ann Rheum Dis; 2021 Dec; 80(12):1604-1614. PubMed ID: 34663597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation.
    Luo T; Zhou X; Qin M; Lin Y; Lin J; Chen G; Liu A; Ouyang D; Chen D; Pan H
    Oxid Med Cell Longev; 2022; 2022():1652244. PubMed ID: 36299604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction.
    Medina JP; Bermejo-Álvarez I; Pérez-Baos S; Yáñez R; Fernández-García M; García-Olmo D; Mediero A; Herrero-Beaumont G; Largo R
    Front Immunol; 2023; 14():1193179. PubMed ID: 37533852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polysaccharide extract from Isatidis Radix inhibits multiple inflammasomes activation and alleviate gouty arthritis.
    Ren L; Li Q; Li H; Zhan X; Yang R; Li Z; Fang Z; Liu T; Wei Z; Zhao J; Lin L; Mou W; Dai W; Bai Z; Xu G; Cao J
    Phytother Res; 2022 Aug; 36(8):3295-3312. PubMed ID: 35666808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autophagy induced by PP121 alleviates MSU crystal-induced acute gouty arthritis via inhibition of the NLRP3 inflammasome.
    Yuan W; Liu T; Wang YY; He S; Zhang F; Wang XB; Deng SH; Zhang T; Wu DM; Xu Y
    Int Immunopharmacol; 2023 Oct; 123():110756. PubMed ID: 37573689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of Syk activation by resveratrol inhibits MSU crystal-induced inflammation in human monocytes.
    Chung YH; Kim HY; Yoon BR; Kang YJ; Lee WW
    J Mol Med (Berl); 2019 Mar; 97(3):369-383. PubMed ID: 30637441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calycosin represses AIM2 inflammasome-mediated inflammation and pyroptosis to attenuate monosodium urate-induced gouty arthritis through NF-κB and p62-Keap1 pathways.
    Tian J; Zhou D; Xiang L; Xie B; Wang B; Li Y; Liu X
    Drug Dev Res; 2022 Nov; 83(7):1654-1672. PubMed ID: 36069386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DUSP1 Mitigates MSU-Induced Immune Response in Gouty Arthritis Reinforcing Autophagy.
    Nie J; Qiu H
    Front Biosci (Landmark Ed); 2024 Jun; 29(6):222. PubMed ID: 38940057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (-)-Epicatechin Ameliorates Monosodium Urate-Induced Acute Gouty Arthritis Through Inhibiting NLRP3 Inflammasome and the NF-κB Signaling Pathway.
    Wu C; Li F; Zhang X; Xu W; Wang Y; Yao Y; Han Z; Xia D
    Front Pharmacol; 2022; 13():799552. PubMed ID: 35462936
    [No Abstract]   [Full Text] [Related]  

  • 39. Tripterine ameliorates monosodium urate crystal-induced gouty arthritis by altering macrophage polarization via the miR-449a/NLRP3 axis.
    Wang Y
    Inflamm Res; 2021 Mar; 70(3):323-341. PubMed ID: 33559709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
    Zhou M; Li S; Song L; Hu Q; Liu W
    Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.